EnVision Endoscopy
Grant in 2024
EnVision Endoscopy specializes in developing innovative medical devices aimed at enhancing endoscopic surgical procedures. Their flagship product is an image-guided suturing system designed to be attached to flexible endoscopes, making it accessible to a wide range of gastroenterologists and surgeons. This biodegradable, single-use device facilitates easier completion of procedures by enabling tissue approximation during surgeries. The company's solutions are intended to reduce procedure time and mortality rates in hospitals, addressing critical clinical needs for policymakers, insurers, clinicians, and patients alike.
Theromics Inc., founded in 2016, develops innovative cell therapies. It specializes in HeatSYNC Gel, a biopolymer thermal accelerant that enhances microwave and radiofrequency energy absorption during soft tissue ablation procedures. This gel amplifies heat movement, optimizes ablation zone shape, increases treatment area, and protects critical tissues.
Advanced Silicon Group
Grant in 2024
Advanced Silicon Group is a nanotechnology company founded in 2015, focused on commercializing innovative silicon nanotechnology developed by its employees. The company specializes in measuring host cell proteins in biomanufacturing, utilizing its advanced technology to enhance various applications, including photovoltaics, lithium-ion batteries, microfluidics, and micro-electromechanical systems (MEMS). Advanced Silicon Group is also engaged in the development of next-generation biosensors, leveraging silicon to enable multiplexed measurements that allow for the simultaneous detection of multiple protein concentrations. This capability aids clients in improving performance and reducing costs by integrating silicon nanowire arrays into their products.
Gel4Med LLC is a Boston-based medical technology company founded in 2015, specializing in the development of innovative biomaterials for tissue treatment and regeneration. The company focuses on creating an antimicrobial tissue-scaffolding matrix that addresses the challenge of antibiotic-resistant bacteria while facilitating tissue regeneration. Utilizing bioinspired and engineering approaches, Gel4Med's technology aims to improve patient outcomes in various therapeutic areas, particularly in wound care and tissue regeneration. Their leading asset features a self-assembling peptide technology that acts as both an antibacterial barrier and a promoter of tissue regeneration, enabling patients to prevent infections during surgical procedures.
Eyebot develops eye examination technology to remove barriers to quality vision care. It provides a freestanding self-serve vision testing terminal that delivers accurate prescriptions at the point of sale through an automated process, supported by a 90-second vision test to streamline assessments and enable ophthalmologists to take a proactive approach to eye care.
Stata DX develops disease management eRapid technology that enables at-home patient monitoring in clinical studies by implementing custom biomarker panels. The company offers a low-cost, affinity-based electrochemical sensing platform capable of simultaneously detecting a broad range of biomarkers with high sensitivity and selectivity in complex biological fluids, including liquid MRI for the brain, providing real-time information about a system's composition for researchers.
EnVision Endoscopy
Convertible Note in 2023
EnVision Endoscopy specializes in developing innovative medical devices aimed at enhancing endoscopic surgical procedures. Their flagship product is an image-guided suturing system designed to be attached to flexible endoscopes, making it accessible to a wide range of gastroenterologists and surgeons. This biodegradable, single-use device facilitates easier completion of procedures by enabling tissue approximation during surgeries. The company's solutions are intended to reduce procedure time and mortality rates in hospitals, addressing critical clinical needs for policymakers, insurers, clinicians, and patients alike.
Founded in Boston in 1995, AmberGen specializes in innovative photonic technology for therapeutics and diagnostics. The company's core expertise lies in proteomics and light-based control of biomolecules, aiming to advance medical research and diagnosis through high-resolution, multiplexed analysis of biomarkers.
Gel4Med LLC is a Boston-based medical technology company founded in 2015, specializing in the development of innovative biomaterials for tissue treatment and regeneration. The company focuses on creating an antimicrobial tissue-scaffolding matrix that addresses the challenge of antibiotic-resistant bacteria while facilitating tissue regeneration. Utilizing bioinspired and engineering approaches, Gel4Med's technology aims to improve patient outcomes in various therapeutic areas, particularly in wound care and tissue regeneration. Their leading asset features a self-assembling peptide technology that acts as both an antibacterial barrier and a promoter of tissue regeneration, enabling patients to prevent infections during surgical procedures.
EnVision Endoscopy
Grant in 2023
EnVision Endoscopy specializes in developing innovative medical devices aimed at enhancing endoscopic surgical procedures. Their flagship product is an image-guided suturing system designed to be attached to flexible endoscopes, making it accessible to a wide range of gastroenterologists and surgeons. This biodegradable, single-use device facilitates easier completion of procedures by enabling tissue approximation during surgeries. The company's solutions are intended to reduce procedure time and mortality rates in hospitals, addressing critical clinical needs for policymakers, insurers, clinicians, and patients alike.
Advanced Silicon Group
Grant in 2023
Advanced Silicon Group is a nanotechnology company founded in 2015, focused on commercializing innovative silicon nanotechnology developed by its employees. The company specializes in measuring host cell proteins in biomanufacturing, utilizing its advanced technology to enhance various applications, including photovoltaics, lithium-ion batteries, microfluidics, and micro-electromechanical systems (MEMS). Advanced Silicon Group is also engaged in the development of next-generation biosensors, leveraging silicon to enable multiplexed measurements that allow for the simultaneous detection of multiple protein concentrations. This capability aids clients in improving performance and reducing costs by integrating silicon nanowire arrays into their products.
PathMaker Neurosystems
Grant in 2023
PathMaker Neurosystems is a clinical-stage neurotechnology company that develops neuromodulation therapies for neuromotor disorders, including amyotrophic lateral sclerosis. The company focuses on non-invasive, multi-site direct current stimulation to modulate neural pathways and spinal motor neurons involved in disease processes. Its approach aims to reduce protein aggregation and motor neuron hyperexcitability, with the goal of improving motor function and potentially extending survival for ALS patients.
Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.
Kinto.Care is an online platform designed to enhance communication and support for caregivers, particularly those caring for loved ones with dementia. The platform offers user-generated content and digital tools that facilitate care team collaboration, medication management, and tracking of health data. By providing practical advice, care planning, and group learning opportunities, Kinto.Care aims to empower family members to effectively coordinate care and manage their loved ones' medical needs through a unified interface.
Founded in Boston in 1995, AmberGen specializes in innovative photonic technology for therapeutics and diagnostics. The company's core expertise lies in proteomics and light-based control of biomolecules, aiming to advance medical research and diagnosis through high-resolution, multiplexed analysis of biomarkers.
EnVision Endoscopy
Grant in 2022
EnVision Endoscopy specializes in developing innovative medical devices aimed at enhancing endoscopic surgical procedures. Their flagship product is an image-guided suturing system designed to be attached to flexible endoscopes, making it accessible to a wide range of gastroenterologists and surgeons. This biodegradable, single-use device facilitates easier completion of procedures by enabling tissue approximation during surgeries. The company's solutions are intended to reduce procedure time and mortality rates in hospitals, addressing critical clinical needs for policymakers, insurers, clinicians, and patients alike.
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, management, and improving overall quality of life.
Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.
PathMaker Neurosystems
Grant in 2022
PathMaker Neurosystems is a clinical-stage neurotechnology company that develops neuromodulation therapies for neuromotor disorders, including amyotrophic lateral sclerosis. The company focuses on non-invasive, multi-site direct current stimulation to modulate neural pathways and spinal motor neurons involved in disease processes. Its approach aims to reduce protein aggregation and motor neuron hyperexcitability, with the goal of improving motor function and potentially extending survival for ALS patients.
Stata DX
Seed Round in 2022
Stata DX develops disease management eRapid technology that enables at-home patient monitoring in clinical studies by implementing custom biomarker panels. The company offers a low-cost, affinity-based electrochemical sensing platform capable of simultaneously detecting a broad range of biomarkers with high sensitivity and selectivity in complex biological fluids, including liquid MRI for the brain, providing real-time information about a system's composition for researchers.
DynamiCare Health
Grant in 2021
DynamiCare Health offers a digital platform that assists individuals in monitoring and reducing their use of drugs, opioids, alcohol, and tobacco. The platform enables users to perform substance tests via an app and tracks treatment attendance using GPS. Healthcare providers can access data on participants' progress through the DynamicCare Analytics portal, which sends real-time risk alerts when clients are at risk.
Kinto.Care is an online platform designed to enhance communication and support for caregivers, particularly those caring for loved ones with dementia. The platform offers user-generated content and digital tools that facilitate care team collaboration, medication management, and tracking of health data. By providing practical advice, care planning, and group learning opportunities, Kinto.Care aims to empower family members to effectively coordinate care and manage their loved ones' medical needs through a unified interface.
Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, management, and improving overall quality of life.
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, management, and improving overall quality of life.
Pendar Technologies
Grant in 2020
Pendar Technologies is a privately held company focused on advancing intelligent chemistry systems by integrating innovative hardware with machine learning algorithms. The company has developed an autonomous chemistry system that utilizes a Raman platform alongside machine-learning techniques to quantify chemical reactants, products, and intermediates in real-time. This technology enables the discovery and scaling of new chemical processes, enhances response capabilities in emergency situations, and contributes to life-saving applications. Pendar's expertise in molecular spectroscopy underpins its efforts to revolutionize the field of chemistry through intelligent and automated solutions.
Physical Sciences
Grant in 2020
Physical Sciences Inc., founded in 1973 and headquartered in Andover, Massachusetts, provides contract research and development services across a wide range of technical areas for both government and commercial clients. The company specializes in advanced imaging and sensing technologies, offering products such as adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, and miniature diode laser-based ambient gas sensors. Additionally, Physical Sciences develops and supplies various analytical technology sensors, mass flux monitors, and laser-based detection systems. The company's engineering services include system engineering, instrument testing and calibration, and the development of electrochemical engineering solutions. It serves diverse markets, including aerospace, energy, biomedical, defense, and telecommunications, through direct sales, strategic partnerships, and licensing agreements both domestically and internationally. With satellite offices in California, Maryland, Ohio, and Massachusetts, as well as a subsidiary in New Jersey, Physical Sciences leverages its extensive expertise to address complex challenges in multiple industries.
MachineMetrics
Convertible Note in 2020
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, management, and improving overall quality of life.
Physical Sciences
Grant in 2020
Physical Sciences Inc., founded in 1973 and headquartered in Andover, Massachusetts, provides contract research and development services across a wide range of technical areas for both government and commercial clients. The company specializes in advanced imaging and sensing technologies, offering products such as adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, and miniature diode laser-based ambient gas sensors. Additionally, Physical Sciences develops and supplies various analytical technology sensors, mass flux monitors, and laser-based detection systems. The company's engineering services include system engineering, instrument testing and calibration, and the development of electrochemical engineering solutions. It serves diverse markets, including aerospace, energy, biomedical, defense, and telecommunications, through direct sales, strategic partnerships, and licensing agreements both domestically and internationally. With satellite offices in California, Maryland, Ohio, and Massachusetts, as well as a subsidiary in New Jersey, Physical Sciences leverages its extensive expertise to address complex challenges in multiple industries.
Kinto.Care is an online platform designed to enhance communication and support for caregivers, particularly those caring for loved ones with dementia. The platform offers user-generated content and digital tools that facilitate care team collaboration, medication management, and tracking of health data. By providing practical advice, care planning, and group learning opportunities, Kinto.Care aims to empower family members to effectively coordinate care and manage their loved ones' medical needs through a unified interface.
Eutropics Pharmaceuticals
Grant in 2019
Eutropics Pharmaceuticals is a team of skilled scientists and project managers that drive LDT and IVD testing from inception through clinical trials. Eutropics investigates apoptosis and immunological signaling networks to find functional biomarkers. The capacity of Eutropics to build unique biomarker assays that profile peripheral blood or bone marrow biopsies has been shown to be useful in AML, CLL, MM, ALL, DLBCL, MDS, and other heme-malignancies.
Pendar Technologies
Grant in 2019
Pendar Technologies is a privately held company focused on advancing intelligent chemistry systems by integrating innovative hardware with machine learning algorithms. The company has developed an autonomous chemistry system that utilizes a Raman platform alongside machine-learning techniques to quantify chemical reactants, products, and intermediates in real-time. This technology enables the discovery and scaling of new chemical processes, enhances response capabilities in emergency situations, and contributes to life-saving applications. Pendar's expertise in molecular spectroscopy underpins its efforts to revolutionize the field of chemistry through intelligent and automated solutions.
MachineMetrics
Series A in 2018
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
Horsepower Technologies
Series A in 2018
Horsepower Technologies Inc. is an animal healthcare company specializing in the manufacture of rehabilitative orthotics for horses. Founded in 2008 and headquartered in Lowell, Massachusetts, the company develops innovative products designed to facilitate the safe recovery of injured horses. Its flagship product, FastTrack, features protective padding for shock absorption and durability, a hard shell cuff for musculoskeletal support, and a mechanism to limit the extension of the fetlock joint. The technology aids in redirecting weight-bearing forces away from healing tendons and ligaments, allowing horses to resume moderate exercise safely and effectively. Horsepower Technologies sells its products online, aiming to enhance recovery outcomes for horses experiencing lameness.
Veritas Genetics
Venture Round in 2018
Veritas Genetics International Ltd. is a genetic testing service provider based in Danvers, Massachusetts, with operations across North America, Asia, and Europe. The company collaborates with scientists, physicians, advisors, and patient advocates to develop and deliver innovative genetic testing solutions. Veritas Genetics utilizes advanced genetic technology that can identify a broader spectrum of gene variations than conventional next-generation sequencing methods. Among its offerings, the company provides a screening test for hereditary breast and ovarian cancer risk, facilitating informed decision-making for clinical researchers and healthcare providers. Through its services, Veritas Genetics aims to empower individuals to lead healthier and longer lives.
Physical Sciences
Grant in 2018
Physical Sciences Inc., founded in 1973 and headquartered in Andover, Massachusetts, provides contract research and development services across a wide range of technical areas for both government and commercial clients. The company specializes in advanced imaging and sensing technologies, offering products such as adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, and miniature diode laser-based ambient gas sensors. Additionally, Physical Sciences develops and supplies various analytical technology sensors, mass flux monitors, and laser-based detection systems. The company's engineering services include system engineering, instrument testing and calibration, and the development of electrochemical engineering solutions. It serves diverse markets, including aerospace, energy, biomedical, defense, and telecommunications, through direct sales, strategic partnerships, and licensing agreements both domestically and internationally. With satellite offices in California, Maryland, Ohio, and Massachusetts, as well as a subsidiary in New Jersey, Physical Sciences leverages its extensive expertise to address complex challenges in multiple industries.
Horsepower Technologies
Venture Round in 2017
Horsepower Technologies Inc. is an animal healthcare company specializing in the manufacture of rehabilitative orthotics for horses. Founded in 2008 and headquartered in Lowell, Massachusetts, the company develops innovative products designed to facilitate the safe recovery of injured horses. Its flagship product, FastTrack, features protective padding for shock absorption and durability, a hard shell cuff for musculoskeletal support, and a mechanism to limit the extension of the fetlock joint. The technology aids in redirecting weight-bearing forces away from healing tendons and ligaments, allowing horses to resume moderate exercise safely and effectively. Horsepower Technologies sells its products online, aiming to enhance recovery outcomes for horses experiencing lameness.
MachineMetrics
Seed Round in 2016
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
Eutropics Pharmaceuticals
Grant in 2016
Eutropics Pharmaceuticals is a team of skilled scientists and project managers that drive LDT and IVD testing from inception through clinical trials. Eutropics investigates apoptosis and immunological signaling networks to find functional biomarkers. The capacity of Eutropics to build unique biomarker assays that profile peripheral blood or bone marrow biopsies has been shown to be useful in AML, CLL, MM, ALL, DLBCL, MDS, and other heme-malignancies.
Veritas Genetics
Venture Round in 2015
Veritas Genetics International Ltd. is a genetic testing service provider based in Danvers, Massachusetts, with operations across North America, Asia, and Europe. The company collaborates with scientists, physicians, advisors, and patient advocates to develop and deliver innovative genetic testing solutions. Veritas Genetics utilizes advanced genetic technology that can identify a broader spectrum of gene variations than conventional next-generation sequencing methods. Among its offerings, the company provides a screening test for hereditary breast and ovarian cancer risk, facilitating informed decision-making for clinical researchers and healthcare providers. Through its services, Veritas Genetics aims to empower individuals to lead healthier and longer lives.
lifeIMAGE
Venture Round in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere.
It was founded in 2008 and headquartered in Newton, Massachusetts.
Energid Technologies
Grant in 2015
Energid Technologies Corporation, founded in 2001 and based in Bedford, Massachusetts, specializes in developing advanced software solutions for robotics. The company is known for its Actin software development kit, which provides real-time and adaptive motion control capabilities. Energid's software addresses complex kinematics and dynamics challenges across various applications, including industrial automation, medical devices, aerospace, agriculture, and defense. By offering products and support tailored to the needs of diverse sectors, Energid Technologies aims to facilitate the deployment of autonomous and collaborative robotic systems, enhancing operational efficiency and precision in demanding environments. As of February 2018, Energid operates as a subsidiary of Teradyne, Inc.
Physical Sciences
Grant in 2015
Physical Sciences Inc., founded in 1973 and headquartered in Andover, Massachusetts, provides contract research and development services across a wide range of technical areas for both government and commercial clients. The company specializes in advanced imaging and sensing technologies, offering products such as adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, and miniature diode laser-based ambient gas sensors. Additionally, Physical Sciences develops and supplies various analytical technology sensors, mass flux monitors, and laser-based detection systems. The company's engineering services include system engineering, instrument testing and calibration, and the development of electrochemical engineering solutions. It serves diverse markets, including aerospace, energy, biomedical, defense, and telecommunications, through direct sales, strategic partnerships, and licensing agreements both domestically and internationally. With satellite offices in California, Maryland, Ohio, and Massachusetts, as well as a subsidiary in New Jersey, Physical Sciences leverages its extensive expertise to address complex challenges in multiple industries.
Energid Technologies
Grant in 2013
Energid Technologies Corporation, founded in 2001 and based in Bedford, Massachusetts, specializes in developing advanced software solutions for robotics. The company is known for its Actin software development kit, which provides real-time and adaptive motion control capabilities. Energid's software addresses complex kinematics and dynamics challenges across various applications, including industrial automation, medical devices, aerospace, agriculture, and defense. By offering products and support tailored to the needs of diverse sectors, Energid Technologies aims to facilitate the deployment of autonomous and collaborative robotic systems, enhancing operational efficiency and precision in demanding environments. As of February 2018, Energid operates as a subsidiary of Teradyne, Inc.
Ande Corporation specializes in providing rapid DNA analysis solutions, focusing on technologies for sample preparation, DNA purification, thermal cycling, amplification, sequencing, and detection. The company's products are designed for various applications including criminal forensics, military human identification, biothreat detection, and clinical diagnostics. Ande's solutions are user-friendly enough to be operated by non-technical personnel outside the laboratory, making them valuable for law enforcement, homeland security, and intelligence communities. Based in Longmont, Colorado, Ande Corporation was incorporated in 2000 and aims to enhance societal safety and health by bringing DNA analysis from the lab to the field.
Radiation Monitoring Devices
Grant in 2013
Radiation Monitoring Devices (RMD), established in 1974 as a business unit of Dynasil Corporation of America, specializes in the development and manufacture of innovative medical instruments for cancer treatment. Their primary product line consists of radiation imaging and detection systems designed to locate radio-labeled cancerous tissue during surgery, enabling safer and more precise patient care.
CapeSym specializes in developing innovative radiation detection solutions. The company manufactures advanced semiconductors designed for nuclear detection, including scintillators such as SrI2(Eu) and CLYC(Ce), as well as TlBr and CdZnTe semiconductors. In addition to its product offerings, CapeSym provides consulting services to corporations and U.S. defense agencies in areas such as thermal management, crystal growth, advanced materials technologies, biomedical devices, and the design and fabrication of industrial equipment. Through these efforts, CapeSym contributes to the imaging industry by delivering effective radiation detectors and thermal analysis techniques.
Incom is a supplier specializing in glass and polymer fused fiber optic solutions, catering to various sectors including medical, scientific, display, and defense industries. The company focuses on providing innovative components and technological expertise to enhance product development and improve user experience for customers, researchers, and instrument makers. Through its advanced solutions, Incom plays a significant role in driving innovation across these diverse fields.
lifeIMAGE
Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere.
It was founded in 2008 and headquartered in Newton, Massachusetts.
lifeIMAGE
Series A in 2009
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere.
It was founded in 2008 and headquartered in Newton, Massachusetts.
MedAptus
Venture Round in 2009
MedAptus, Inc. is a provider of clinical workforce and workflow solutions tailored for healthcare environments, including hospitals, health systems, and group practices. The company's offerings encompass a range of charge capture technologies designed to enhance the efficiency of healthcare providers. Key products include Pro Charge Capture, which assists physicians and administrative staff in managing billing and coding; Assign for Rounding Providers and Assign for Care Team Members, which optimize patient assignments; and MedAptus Collaborate, a secure communication tool for caregivers. Additional solutions include various editions addressing the specific needs of different healthcare settings, such as inpatient care, outpatient clinics, and academic practice plans. Founded in 1999 and based in Boston, Massachusetts, MedAptus aims to streamline clinical operations, improve patient management, and facilitate collaboration among care teams. The company was previously known as MedCompanion, Inc. and became a subsidiary of Volaris Group Inc. in 2020.
Atlantis Components
Series D in 2007
Atlantis Components specializes in the design and manufacturing of titanium abutments for implant dentistry, utilizing a proprietary software system known as the Virtual Abutment Design (VAD) system. This innovative system enables technicians to create abutments with unprecedented precision and reliability, enhancing the restoration of dental implants through crown-and-bridge techniques. Atlantis Components' designs are grounded in comprehensive dental research and clinical insights, ensuring that their products meet the needs of dental professionals and improve patient outcomes. The company's commitment to quality and precision positions it as a leader in the field of dental implant solutions.
CardioFocus
Series C in 2001
CardioFocus develops endoscopic ablation systems for atrial fibrillation, including the HeartLight Endoscopic Ablation System with direct visualization and energy-delivery capabilities for pulmonary vein isolation, as well as the HeartLight Excalibur Balloon and HeartLight X3 System for stable tissue contact and controlled lesion creation across varying pulmonary vein anatomies. The company integrates a balloon catheter, endoscope, deflectable sheath, and console to enable electrophysiologists to tailor ablations to patient needs. Founded in 1990 and based in Marlborough, Massachusetts, CardioFocus aims to advance treatment of cardiac arrhythmias through visualization-guided devices.
CytoLogix
Series B in 2001
CytoLogix is a private company that focuses on developing laboratory instrumentation for non-routine complex stains. The company develops the Artisan, a tissue staining instrument used primarily for cancer diagnosis. It claims that the instrument was the first instrument to provide true walk-away automation for both immunohistochemical and complex special stains.
EndoVia Medical
Series C in 2000
EndoVia Medical is a developer of physician-guided robotic systems for minimally invasive surgery. It develops the Laprotek system, a robotic instrument system for minimally invasive surgeries including general surgery, urology, gynecology, and bariatric surgery, and the ViaCath system, a user interface, and instrument control platform, that allows the surgeon to manipulate catheter instruments deep inside the patient.
CardioFocus
Series B in 2000
CardioFocus develops endoscopic ablation systems for atrial fibrillation, including the HeartLight Endoscopic Ablation System with direct visualization and energy-delivery capabilities for pulmonary vein isolation, as well as the HeartLight Excalibur Balloon and HeartLight X3 System for stable tissue contact and controlled lesion creation across varying pulmonary vein anatomies. The company integrates a balloon catheter, endoscope, deflectable sheath, and console to enable electrophysiologists to tailor ablations to patient needs. Founded in 1990 and based in Marlborough, Massachusetts, CardioFocus aims to advance treatment of cardiac arrhythmias through visualization-guided devices.
CardioFocus
Series A in 1998
CardioFocus develops endoscopic ablation systems for atrial fibrillation, including the HeartLight Endoscopic Ablation System with direct visualization and energy-delivery capabilities for pulmonary vein isolation, as well as the HeartLight Excalibur Balloon and HeartLight X3 System for stable tissue contact and controlled lesion creation across varying pulmonary vein anatomies. The company integrates a balloon catheter, endoscope, deflectable sheath, and console to enable electrophysiologists to tailor ablations to patient needs. Founded in 1990 and based in Marlborough, Massachusetts, CardioFocus aims to advance treatment of cardiac arrhythmias through visualization-guided devices.
Highland Instruments is a Braintree, MA-based company founded in 2017, specializing in the development of noninvasive brain stimulation technologies. The firm is focused on pioneering ElectroSonic Stimulation technology, specifically its ESStimâ„¢ system, which aims to address brain-based movement disorders and chronic pain management. Highland Instruments' medical devices leverage this innovative technology to provide relief for conditions such as osteoarthritis of the knee, enhancing patient quality of life by alleviating pain through noninvasive means.